ISONIAZID, powder, 5 g [Sigma-Fluka-I3377]
STD
SASTAPWDINH5
Valid Article
Account code:
60200
HS Code:
382290
Last Updated on:
12/04/2024, 15:40:13
Former
Code(s):
SLASISON5P-
Single use
A single-use device, also referred to as a disposable device, is intended for use on one patient during a single procedure. It is not intended to be reprocessed (i.e., cleaned and disinfected or sterilized).
W0104010699 - Media for mycobacteria cultures - manual & automated (for ast drugs , supplements) - other
European Medical Device Nomenclature (EMDN) is the nomenclature of use by manufacturers when registering their medical devices in the EUDAMED database. EMDN is characterised by its alphanumeric structure that is established in a seven-level hierarchical tree.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
ISONIAZID
Reserved for TB culture programmes.
Definition
Antimycobacterial used for drug susceptibility testing of M. tuberculosis complex.
Synonym
Isonicotinic acid hydrazide, INH Isonitinic hydrazide
Specifications
Some restricted information has been hidden. Sign in
to see this information
Technical specifications
- White powder
- Soluble in water
- Formula : C6H7N3O
- Purity : >= 99%
Packaging & Labelling
5 g in glass vial
Transport not regulated
Instructions for use
For the procedure of the stock solution and working solution preparations, refer to Tuberculosis Culture Laboratory, MSF-ITM, 2014.
Avoid contact with skin and eyes.
Storage
- Store in a cool place
- Keep container tightly closed in a dry and well-ventilated place
- Avoid formation of dust and aerosols
- Provide appropriate exhaust ventilation at places where dust is formed
Classification EC Regulation N° 1272/2008
- Acute toxicity, Oral : Category 4
- Skin irritation : Category 2
Signal Word
Warning
H302 | Harmful if swallowed |
H315 | Causes skin irritation |
MSF requirements
Isoniazid is one of the first line drugs used against M. tuberculosis complex. The test is performed to investigate resistance of the mycobacterium to this antibiotic. The drug solution is added to agar or egg-based media during preparation.
Some restricted information has been hidden. Sign in
to see this information
Some restricted information has been hidden. Sign in
to see this information